Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 18 and younger than 85 years of age
- People who have been diagnosed with a specific type of stomach cancer called gastric adenocarcinoma, confirmed by a tissue sample taken before surgery
- People whose cancer has been assessed before surgery as being at a certain stage — not too early and not spread to distant parts of the body (confirm with trial site for full staging details)
- People who have had their entire stomach removed along with a specific type of lymph node removal procedure called D2 lymphadenectomy plus complete mesogastric excision
- People who have been assessed by an anaesthesiologist as being in a certain level of fitness for surgery (rated as class I, II, or III on a standard medical scale)
- People who have provided written agreement to take part in the trial
Who may not be able to join:
- People whose tissue sample taken before surgery did not show cancer cells
- People whose cancer has reached a very advanced local stage or has spread to other parts of the body
- People with a Body Mass Index (BMI) above 30 kg/m² (a measure of body weight relative to height)
- People who have already received chemotherapy or radiation therapy before surgery for this cancer
- People who have had a previous surgery on the upper part of the abdomen
- People who have another type of cancer in addition to stomach cancer
- People who have declined or refused surgery
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-197-068-25286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of lymph node metastasis and tumor deposit in the short gastric mesentery
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.